|
PIKFYVE expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65667479734566E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.59410040723174E-10 |
| Normal-vs-Stage2 |
6.71350000036597E-07 |
| Normal-vs-Stage3 |
8.34887714518118E-13 |
| Normal-vs-Stage4 |
2.73570055497885E-11 |
| Stage1-vs-Stage2 |
7.787200E-01 |
| Stage1-vs-Stage3 |
2.423600E-02 |
| Stage1-vs-Stage4 |
6.995500E-03 |
| Stage2-vs-Stage3 |
1.887420E-01 |
| Stage2-vs-Stage4 |
8.743800E-02 |
| Stage3-vs-Stage4 |
5.655000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.41553435639707E-13 |
| Normal-vs-AfricanAmerican |
1.192460E-04 |
| Normal-vs-Asian |
1.67329999856136E-08 |
| Caucasian-vs-AfricanAmerican |
5.710200E-01 |
| Caucasian-vs-Asian |
7.720400E-01 |
| AfricanAmerican-vs-Asian |
4.501800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.89830398464619E-13 |
| Normal-vs-Female |
3.96505051014628E-12 |
| Male-vs-Female |
2.782600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.83110004936538E-09 |
| Normal-vs-Age(41-60Yrs) |
3.74111852607939E-12 |
| Normal-vs-Age(61-80Yrs) |
5.41378053497965E-12 |
| Normal-vs-Age(81-100Yrs) |
1.163200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.105970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.560000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.480600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.645600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.807800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.730600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.115800E-02 |
| Classical-VS-Follicular |
6.858600E-01 |
| Classical-VS-Other |
1.921830E-01 |
| Classical-VS-Normal |
7.15116854621556E-12 |
| Tall-VS-Follicular |
7.144000E-02 |
| Tall-VS-Other |
8.161600E-01 |
| Tall-VS-Normal |
4.53340032180449E-10 |
| Follicular-VS-Other |
3.403600E-01 |
| Follicular-VS-Normal |
8.87429999485434E-08 |
| Other-VS-Normal |
7.778200E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.15489906105904E-13 |
| Normal-vs-N1 |
1.08529996101225E-09 |
| N0-vs-N1 |
3.337800E-01 |
|
|
